A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization
/in International Publications, Newcastle Disease VirusDendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
/in Dendritic Cells, International Publications, Prostate CancerImmuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
/in International Publications, Prostate Cancer[Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice]
/in International Publications, Pancreatic CancerVaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests
/in Colorectal Cancer, Dendritic Cells, International PublicationsCurrent state and perspectives of dendritic cell vaccination in cancer immunotherapy
/in Dendritic Cells, International PublicationsCurrent progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia
/in Acute Leukemia, International PublicationsImmunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts
/in Acute Leukemia, International PublicationsSensitization of malignant glioma to chemotherapy through dendritic cell vaccination
/in Glioblastoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer